Perspective · 28 Feb 2025
Mini reviewPublished 20 Jun 2017
NLRP3 Inflammasome: From Pathogenesis to Therapeutic Strategies in Type 1 Diabetes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by a T-cell-mediated destruction of the pancreatic β cells. Several environmental factors have been proposed as candidate triggers for T1DM, considering that a genetic predisposition alone is not sufficient to explain the increasing incidence rates over the past decades. This organ-specific autoimmune disease is the consequence of multifactorial processes involving dysregulation of the innate and adaptive immune systems that lead the body to damage insulin-producing β cells. In this review, we reported the contribution of innate immune receptors in modulating the pathogenic lymphocyte responses in T1DM development, with a particular emphasis to NLRP3, which can be considered as a potential therapeutic target to treat T1DM.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Autoimmune Disorders.
Commentary · 28 Feb 2025
Nanomedicine in the Diagnosis and Treatment of Autoimmune Disorders
Short communication · 28 Feb 2025
Immune Checkpoints and Their Dysregulation in Autoimmunity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Autoimmune Disorders
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Daniela Carlos”
